EP3677591
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.4.2013EP published:
28.12.2022EP application number:
19213030.0
EPO information:
European Patent Register
Max expiry date:
28.4.2033
Title in English:
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2BLanguage of the patent:
English
Timeline
Today
29.4.2013EP application
28.12.2022EP Publication
Owner
Name:
Teva Pharmaceuticals Australia Pty LtdAddress:
Level 2 37 Epping Road, Macquarie Park, NSW 2113, AU
Inventor
Name:
CLARKE, AdamAddress:
NSW 2113, AU
Name:
POLLARD, MatthewAddress:
NSW 2113, AU
Name:
DOYLE, Anthony, GerardAddress:
NSW 2113, AU
Name:
BEHRENS, ColletteAddress:
NSW 2113, AU
Name:
YAMAGISHI, TetsuoAddress:
NSW 2113, AU
Name:
WILSON, David, S. Jr.Address:
Redwood City, California 94063, US
Name:
POGUE, Sarah, L.Address:
Fremont, California 94536-1703, US
Name:
TAURA, TetsuyaAddress:
Palo Alto, California 94306, US
Classification
Categories:
C07K 14/56, C07K 16/28, A61K 38/21, A61P 35/00, A61P 35/02